The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. - Wikidata - wikimedia - TriplyDB

The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.

The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.

http://www.wikidata.org/entity/Q40559475

about

A novel ubiquitin-binding protein ZNF216 functioning in muscle atrophy Muscle atrophy in transgenic mice expressing a human TSC1 transgene The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy Cancer cachexia--pathophysiology and management Skeletal muscle protein balance in mTOR heterozygous mice in response to inflammation and leucine Peroxisome proliferator-activated receptor gamma coactivator 1alpha or 1beta overexpression inhibits muscle protein degradation, induction of ubiquitin ligases, and disuse atrophy Fed-state clamp stimulates cellular mechanisms of muscle protein anabolism and modulates glucose disposal in normal men Exercise and health: can biotechnology confer similar benefits?Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failure In Vivo Rodent Models of Skeletal Muscle Adaptation to Decreased Use Long live FOXO: unraveling the role of FOXO proteins in aging and longevity Biochemical Genetic Pathways that Modulate Aging in Multiple Species Connecting Myokines and Metabolism FOXO transcription factors: key regulators of cellular quality control Autophagy is essential to support skeletal muscle plasticity in response to endurance exercise Cellular and molecular mechanisms of muscle atrophy Role of autophagy in COPD skeletal muscle dysfunction IL-6 and IGF-1 Signaling Within and Between Muscle and Bone: How Important is the mTOR Pathway for Bone Metabolism?Targeting the ubiquitin-proteasome system in heart disease: the basis for new therapeutic strategies Statin-Induced Increases in Atrophy Gene Expression Occur Independently of Changes in PGC1α Protein and Mitochondrial Content Muscle-specific SIRT1 gain-of-function increases slow-twitch fibers and ameliorates pathophysiology in a mouse model of duchenne muscular dystrophy Leptin administration favors muscle mass accretion by decreasing FoxO3a and increasing PGC-1alpha in ob/ob mice Metabolic benefits of resistance training and fast glycolytic skeletal muscle.Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?Inflammatory Mechanisms Associated with Skeletal Muscle Sequelae after Stroke: Role of Physical Exercise Disrupted autophagy undermines skeletal muscle adaptation and integrity FoxO1: a novel insight into its molecular mechanisms in the regulation of skeletal muscle differentiation and fiber type specification mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass Emerging drugs for sarcopenia: age-related muscle wasting Distinct protein degradation profiles are induced by different disuse models of skeletal muscle atrophy Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis Swimming exercise prevents fibrogenesis in chronic kidney disease by inhibiting the myofibroblast transdifferentiation Glucocorticoid-induced leucine zipper (GILZ) and long GILZ inhibit myogenic differentiation and mediate anti-myogenic effects of glucocorticoids Insulin-like growth factor 1 receptor signaling regulates skin development and inhibits skin keratinocyte differentiation Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo The p97/VCP ATPase is critical in muscle atrophy and the accelerated degradation of muscle proteins Reversal of muscle atrophy by Zhimu-Huangbai herb-pair via Akt/mTOR/FoxO3 signal pathway in streptozotocin-induced diabetic mice β-Hydroxy β-methylbutyrate improves dexamethasone-induced muscle atrophy by modulating the muscle degradation pathway in SD rat Regulation of signaling pathways downstream of IGF-I/insulin by androgen in skeletal muscle of glucocorticoid-treated rats Plasminogen activator inhibitor type 1 up-regulation is associated with skeletal muscle atrophy and associated fibrosis

P2860

Q24301547-355D0C8B-B58E-4D7F-A262-0E6E98DB5F65 Q24304304-2B6A473E-FF95-4969-A9EA-2E80B5FD1EE4 Q24312951-6EC0449D-1831-48B1-A5AC-C453F5220306 Q24605567-7391DAEA-AFFE-4808-9F67-8E74450C60E1 Q24633679-40D067FA-26F0-44BF-9A26-DB711AD04187 Q24634396-9E506F65-5712-4207-AE4C-2C8CF5C6CCDE Q24656983-D3404F8A-EB44-4976-8B8F-DEABF3DC2754 Q24805354-50D27078-86C7-4D21-A2B2-E4C7FCE277D3 Q26745026-2BDFC6A6-718F-4F5A-9EFA-96B9F534C09D Q26753187-4E1C7B3A-4BDF-47F2-A701-280F39F8B6FC Q26773901-1C2F2D1D-A222-4E29-9B39-95C7ECA1EBF9 Q26777407-B6C0715A-7E68-4C71-8642-3723C9B35660 Q26801402-8B10CE26-7349-4539-AC0F-E4DAE6416710 Q26851722-84AF33D8-E7CC-48A9-8DA3-2379BC6D7C90 Q27000625-DFE44A4A-7C7B-4D54-B14A-7DD761F49D8A Q27012762-66886E1D-658C-495F-8A76-8696C52A74DD Q27015002-AA88A0BA-F505-4CAB-998A-7E7AEA7F4460 Q27024703-F2611FBA-79F7-4550-BC89-DAF8716284F6 Q27026951-038A9CA3-4B35-4DC1-8EB9-9A646D3C74F2 Q27305332-A1CFEB59-88DF-476E-AAF5-B3161D64246A Q27314850-6F9B2290-83D0-4453-A12D-5EB0F075044E Q27342830-B3CB5048-3DD7-45B2-979D-3B5D85048D45 Q27687459-9A76AE15-870E-46EF-938A-CBF492469F91 Q28068034-A61B82FC-B6B3-4D8E-A0AC-DD4ED0055488 Q28076878-9D72A0EC-A319-48C1-BF67-9C4F52D57D50 Q28077297-727B974C-D3DE-47E2-A52C-8AAC6A98E8CD Q28080095-85F22470-9868-4A1E-A06C-15FE0E3E4EDE Q28239563-38BB8ED0-3FA8-43CA-A0F1-2C05F4581895 Q28295716-13C62CA2-3610-4709-9512-ED16CA7A83A0 Q28393718-0E6555FC-7386-4A4E-A2B2-CDB992E4E677 Q28477076-A8D4D9EE-B35E-4569-8059-77AE0548AA9F Q28480806-2317A3BE-46D0-498C-A187-1A0730AE83BE Q28509978-BA804D7F-8946-4E58-B485-A018758E0EE8 Q28512393-E953BE3F-5EA1-4916-A3BB-B74321B0CC1C Q28512771-8F819F53-B9C4-48BD-9912-C12A77EDA0A0 Q28513793-1A94811A-D77B-4F96-A8F0-D1970A6A9C00 Q28540078-5CA2921E-9624-4A8D-A177-1F4CB9AE9EC5 Q28540883-332F9AAA-342D-406A-A421-7730A8113DE7 Q28564515-D4236C85-825D-4420-A5B3-AEC7C3D0C73F Q28566526-E223C40F-3A7F-41F2-85E1-A1765A307367

P2860

The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.

http://www.wikidata.org/entity/Q40559475

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

The IGF-1/PI3K/Akt pathway pre ...... ng FOXO transcription factors.

@en

type

label

The IGF-1/PI3K/Akt pathway pre ...... ng FOXO transcription factors.

@en

prefLabel

The IGF-1/PI3K/Akt pathway pre ...... ng FOXO transcription factors.

@en

P1433

Q40559475-611E40CF-D8BF-42F5-8AC3-D0A44E64C2F3

P1476

Q40559475-1EF0F8BB-17AB-4E7B-BE26-82B8F89D17BE

P2093

Q40559475-00C5C26F-4D4A-43D6-847F-B8D885D5B7AA

Q40559475-49C0260C-DCB4-4613-8747-A082A32865DB

Q40559475-505A44CF-CDF9-4D57-95ED-01635365DAF3

Q40559475-61529A6D-2D09-4B14-AB5D-F0C4CC82423F

Q40559475-70B54709-F2CB-45B2-BD44-AD9DA8426A90

Q40559475-77C74532-D05B-4B94-9013-A6FC8167EF1A

Q40559475-7F59A806-6DB6-409C-B629-F0BCB8646A1A

Q40559475-86B333D8-34C6-414D-81C4-5DC7EB9F40F1

Q40559475-B1C356D1-0273-4051-A534-9D5974CF5BDD

P304

Q40559475-B70B1E9F-85CA-43B8-8188-48F10CEC2A44

P31

Q40559475-60FCC397-6799-4870-8B59-D24A8EB1078B

P356

Q40559475-1B20D9B7-D806-4913-8208-EDD996822C14

P433

Q40559475-32F43992-D5B1-4AF6-A7A6-B4DCFB4FA44D

P478

Q40559475-106597A8-BBDF-49B8-8425-DE1EDC9285BB

P577

Q40559475-591DF4DC-0A5A-4DD3-805A-CAA9EF2E50B9

P698

Q40559475-40CCDC0D-13A6-4DC7-B5C7-0AB74527069B

P356

S1097-2765(04)00211-4

P1433

P1476

The IGF-1/PI3K/Akt pathway pre ...... ng FOXO transcription factors.

@en

P2093

Brian A Clarke

http://www.w3.org/2001/XMLSchema#string

David J Glass

http://www.w3.org/2001/XMLSchema#string

Doreen Drujan

http://www.w3.org/2001/XMLSchema#string

Frank Panaro

http://www.w3.org/2001/XMLSchema#string

George D Yancopoulos

http://www.w3.org/2001/XMLSchema#string

Michael Gonzalez

http://www.w3.org/2001/XMLSchema#string

Trevor N Stitt

http://www.w3.org/2001/XMLSchema#string

William O Kline

http://www.w3.org/2001/XMLSchema#string

Yekatarina Timofeyva

http://www.w3.org/2001/XMLSchema#string

P304

395-403

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1097-2765(04)00211-4

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2004-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15125842

http://www.w3.org/2001/XMLSchema#string